Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Edesa Biotech, Inc. | v453489_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - Edesa Biotech, Inc. | v453489_ex32-2.htm |
| EX-31.2 - EXHIBIT 31.2 - Edesa Biotech, Inc. | v453489_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - Edesa Biotech, Inc. | v453489_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - Edesa Biotech, Inc. | v453489_ex23-1.htm |
Exhibit 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Stellar Biotechnologies, Inc. (the “Company”) for the fiscal year ended September 30, 2016 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, I, Frank R. Oakes, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: December 14, 2016 | By: | /s/ Frank R. Oakes |
| Frank R. Oakes | ||
| President and Chief Executive Officer | ||
| (Principal Executive Officer) |